Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice

<b>Background:</b> Although mRNA vaccines encapsulated in lipid nanoparticles (LNPs) have demonstrated a safety profile with minimal serious adverse events in clinical trials, there is opportunity to further reduce mRNA reactogenicity. The development of naked mRNA vaccines could improve...

Full description

Saved in:
Bibliographic Details
Main Authors: Denis N. Kisakov, Larisa I. Karpenko, Lyubov A. Kisakova, Sergey V. Sharabrin, Mariya B. Borgoyakova, Ekaterina V. Starostina, Oleg S. Taranov, Elena K. Ivleva, Oleg V. Pyankov, Anna V. Zaykovskaya, Elena V. Dmitrienko, Vladimir A. Yakovlev, Elena V. Tigeeva, Irina Alekseevna Bauer, Svetlana I. Krasnikova, Nadezhda B. Rudometova, Andrey P. Rudometov, Artemiy A. Sergeev, Alexander A. Ilyichev
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/1/65
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587365079580672
author Denis N. Kisakov
Larisa I. Karpenko
Lyubov A. Kisakova
Sergey V. Sharabrin
Mariya B. Borgoyakova
Ekaterina V. Starostina
Oleg S. Taranov
Elena K. Ivleva
Oleg V. Pyankov
Anna V. Zaykovskaya
Elena V. Dmitrienko
Vladimir A. Yakovlev
Elena V. Tigeeva
Irina Alekseevna Bauer
Svetlana I. Krasnikova
Nadezhda B. Rudometova
Andrey P. Rudometov
Artemiy A. Sergeev
Alexander A. Ilyichev
author_facet Denis N. Kisakov
Larisa I. Karpenko
Lyubov A. Kisakova
Sergey V. Sharabrin
Mariya B. Borgoyakova
Ekaterina V. Starostina
Oleg S. Taranov
Elena K. Ivleva
Oleg V. Pyankov
Anna V. Zaykovskaya
Elena V. Dmitrienko
Vladimir A. Yakovlev
Elena V. Tigeeva
Irina Alekseevna Bauer
Svetlana I. Krasnikova
Nadezhda B. Rudometova
Andrey P. Rudometov
Artemiy A. Sergeev
Alexander A. Ilyichev
author_sort Denis N. Kisakov
collection DOAJ
description <b>Background:</b> Although mRNA vaccines encapsulated in lipid nanoparticles (LNPs) have demonstrated a safety profile with minimal serious adverse events in clinical trials, there is opportunity to further reduce mRNA reactogenicity. The development of naked mRNA vaccines could improve vaccine tolerability. Naked nucleic acid delivery using the jet injection method may be a solution. <b>Methods:</b> In the first part of the study, the optimal conditions providing low traumatization and high expression of the model mRNA-GFP molecule in the tissues of laboratory animals were determined. Then, we used the selected protocol to immunize BALB/c mice with mRNA-RBD encoding the SARS-CoV-2 receptor-binding domain (RBD). It was demonstrated that mice vaccinated with naked mRNA-RBD developed a high level of specific antibodies with virus-neutralizing activity. The vaccine also induced a strong RBD-specific T-cell response and reduced the viral load in the lungs of the animals after infection with the SARS-CoV-2 virus. The level of immune response in mice immunized with mRNA-RBD using a spring-loaded jet injector was comparable to that in animals immunized with mRNA-RBD encapsulated in LNPs. <b>Results:</b> In this study, the efficacy of an inexpensive, simple, and safe method of mRNA delivery using a spring-loaded jet injector was evaluated and validated. <b>Conclusions:</b> Our findings suggest that the jet injection method may be a possible alternative to LNPs for delivering mRNA vaccines against SARS-CoV-2 infection.
format Article
id doaj-art-829b09024e724a0983b717fad54d4412
institution Kabale University
issn 2076-393X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-829b09024e724a0983b717fad54d44122025-01-24T13:51:49ZengMDPI AGVaccines2076-393X2025-01-011316510.3390/vaccines13010065Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in MiceDenis N. Kisakov0Larisa I. Karpenko1Lyubov A. Kisakova2Sergey V. Sharabrin3Mariya B. Borgoyakova4Ekaterina V. Starostina5Oleg S. Taranov6Elena K. Ivleva7Oleg V. Pyankov8Anna V. Zaykovskaya9Elena V. Dmitrienko10Vladimir A. Yakovlev11Elena V. Tigeeva12Irina Alekseevna Bauer13Svetlana I. Krasnikova14Nadezhda B. Rudometova15Andrey P. Rudometov16Artemiy A. Sergeev17Alexander A. Ilyichev18State Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, 630090 Novosibirsk, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaInstitute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, 630090 Novosibirsk, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, RussiaState Research Center of Virology and Biotechnology “Vector”, Rospotrebnadzor, World-Class Genomic Research Center for Biological Safety and Technological Independence, Federal Scientific and Technical Program on the Development of Genetic Technologies, 630559 Koltsovo, Russia<b>Background:</b> Although mRNA vaccines encapsulated in lipid nanoparticles (LNPs) have demonstrated a safety profile with minimal serious adverse events in clinical trials, there is opportunity to further reduce mRNA reactogenicity. The development of naked mRNA vaccines could improve vaccine tolerability. Naked nucleic acid delivery using the jet injection method may be a solution. <b>Methods:</b> In the first part of the study, the optimal conditions providing low traumatization and high expression of the model mRNA-GFP molecule in the tissues of laboratory animals were determined. Then, we used the selected protocol to immunize BALB/c mice with mRNA-RBD encoding the SARS-CoV-2 receptor-binding domain (RBD). It was demonstrated that mice vaccinated with naked mRNA-RBD developed a high level of specific antibodies with virus-neutralizing activity. The vaccine also induced a strong RBD-specific T-cell response and reduced the viral load in the lungs of the animals after infection with the SARS-CoV-2 virus. The level of immune response in mice immunized with mRNA-RBD using a spring-loaded jet injector was comparable to that in animals immunized with mRNA-RBD encapsulated in LNPs. <b>Results:</b> In this study, the efficacy of an inexpensive, simple, and safe method of mRNA delivery using a spring-loaded jet injector was evaluated and validated. <b>Conclusions:</b> Our findings suggest that the jet injection method may be a possible alternative to LNPs for delivering mRNA vaccines against SARS-CoV-2 infection.https://www.mdpi.com/2076-393X/13/1/65mRNA vaccinesneedle-free jet injectionlipid nanoparticlesRBDSARS-CoV-2immune response
spellingShingle Denis N. Kisakov
Larisa I. Karpenko
Lyubov A. Kisakova
Sergey V. Sharabrin
Mariya B. Borgoyakova
Ekaterina V. Starostina
Oleg S. Taranov
Elena K. Ivleva
Oleg V. Pyankov
Anna V. Zaykovskaya
Elena V. Dmitrienko
Vladimir A. Yakovlev
Elena V. Tigeeva
Irina Alekseevna Bauer
Svetlana I. Krasnikova
Nadezhda B. Rudometova
Andrey P. Rudometov
Artemiy A. Sergeev
Alexander A. Ilyichev
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
Vaccines
mRNA vaccines
needle-free jet injection
lipid nanoparticles
RBD
SARS-CoV-2
immune response
title Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
title_full Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
title_fullStr Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
title_full_unstemmed Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
title_short Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
title_sort jet injection of naked mrna encoding the rbd of the sars cov 2 spike protein induces a high level of a specific immune response in mice
topic mRNA vaccines
needle-free jet injection
lipid nanoparticles
RBD
SARS-CoV-2
immune response
url https://www.mdpi.com/2076-393X/13/1/65
work_keys_str_mv AT denisnkisakov jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT larisaikarpenko jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT lyubovakisakova jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT sergeyvsharabrin jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT mariyabborgoyakova jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT ekaterinavstarostina jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT olegstaranov jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT elenakivleva jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT olegvpyankov jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT annavzaykovskaya jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT elenavdmitrienko jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT vladimirayakovlev jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT elenavtigeeva jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT irinaalekseevnabauer jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT svetlanaikrasnikova jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT nadezhdabrudometova jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT andreyprudometov jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT artemiyasergeev jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice
AT alexanderailyichev jetinjectionofnakedmrnaencodingtherbdofthesarscov2spikeproteininducesahighlevelofaspecificimmuneresponseinmice